Correlation of pre-CAR CD19 expression with responses and relapses after CAR T cell therapy.
2018
3051Background:
Chimeric antigen receptor(CAR) T cells targeting
CD19have shown excellent responses in patients with relapsed/refractory B-ALL. However, a subset of patients either do not respond...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
3
Citations
NaN
KQI